miR-223-3p promotes cell proliferation and invasion by targeting Arid1a in gastric cancer.

In conclusion, our results demonstrated that miR-223-3p inhibits gastric cancer cell progression by decreasing the expression of Arid1a. Therefore, miR-223-3p may act as a potential therapeutic target for patients with gastric cancer.
PMID: 31912865 [PubMed - as supplied by publisher]

Source: Acta Biochimica et Biophysica Sinica - January 7, 2020 Category: Biochemistry Authors: Zhu Y, Li K, Yan L, He Y, Wang L, Sheng L Tags: Acta Biochim Biophys Sin (Shanghai) Source Type: research